Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Giant cell (GCA) and Takayasu's arteritis (TAK) are 2 forms of large-vessel vasculitis (LVV) that involve the aorta and its major branches. GCA has a predilection for the cranial branches, while TAK tends to affect the extracranial branches. Both disorders may also cause nonspecific constitutio...

Podrobná bibliografie
Hlavní autoři:	Direskeneli, H, Aydin, S, Kermani, T, Matteson, E, Boers, M, Herlyn, K, Luqmani, R, Neogi, T, Seo, P, Suppiah, R, Tomasson, G, Merkel, P
Médium:	Journal article
Jazyk:	English
Vydáno:	2011

Podobné jednotky

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
Autor: Merkel, P, a další
Vydáno: (2011)

Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.
Autor: Merkel, P, a další
Vydáno: (2009)

Current status of outcome measure development in vasculitis.
Autor: Merkel, P, a další
Vydáno: (2014)

DIAGNOSIS AND ASSESSMENT OF LARGE VESSEL VASCULITIS
Autor: Luqmani, R
Vydáno: (2011)

Systemic vasculitis--is it time to reclassify?
Autor: Watts, R, a další
Vydáno: (2011)

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
Autor: Luqmani, R, a další
Vydáno: (2011)

The future of damage assessment in vasculitis.
Autor: Seo, P, a další
Vydáno: (2007)

The use of ultrasound in the management of large-vessel vasculitis: an evolving concept
Autor: Monti, S, a další
Vydáno: (2018)

EULAR recommendations for the management of large vessel vasculitis.
Autor: Mukhtyar, C, a další
Vydáno: (2009)

Outcome in small-vessel systemic vasculitis.
Autor: Luqmani, R, a další
Vydáno: (2006)

Assessment of damage in vasculitis: Expert ratings of damage
Autor: Seo, P, a další
Vydáno: (2008)

Assessment of damage in vasculitis: expert ratings of damage.
Autor: Seo, P, a další
Vydáno: (2009)

Outcome measures in ANCA-associated vasculitis.
Autor: Suppiah, R, a další
Vydáno: (2010)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
Autor: Walsh, M, a další
Vydáno: (2011)

Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.
Autor: Merkel, P, a další
Vydáno: (2005)

Advances in the classification of primary systemic vasculitis
Autor: Suppiah, R, a další
Vydáno: (2009)

The need for diagnostic criteria in systemic vasculitis
Autor: Suppiah, R, a další
Vydáno: (2011)

Assessment of damage in vasculitis: expert ranking of items of damage
Autor: Seo, P, a další
Vydáno: (2007)

REVIEW OF THE EXPERT PANEL METHODOLOGY IN THE DIAGNOSTIC AND CLASSIFICATION CRITERIA FOR VASCULITIS STUDY: A PILOT STUDY
Autor: Pante, C, a další
Vydáno: (2014)

Review Of The Expert Panel Methodology In The Diagnostic and Classification Criteria For Vasculitis Study: A Pilot Study
Autor: Ponte, C, a další
Vydáno: (2013)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
Autor: Despina Michailidou, a další
Vydáno: (2022-06-01)

Vasculitogenic T Cells in Large Vessel Vasculitis
Autor: Ryu Watanabe, a další
Vydáno: (2022-06-01)

An Unusual Case of Large-Vessel Vasculitis
Autor: Omar Suhail Alsaed, a další
Vydáno: (2018-05-01)

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).
Autor: Craven, A, a další
Vydáno: (2013)

Disease activity assessment in large vessel vasculitis
Autor: N. Pipitone, a další
Vydáno: (2011-09-01)

Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?
Autor: Seeliger, B, a další
Vydáno: (2017)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
Autor: Robson, J, a další
Vydáno: (2017)

Cutaneous manifestations of ANCA-associated vasculitis
Autor: Chiesafuxench, Z, a další
Vydáno: (2016)

EULAR recommendations for the management of primary small and medium vessel vasculitis.
Autor: Mukhtyar, C, a další
Vydáno: (2009)

Current imaging techniques in large vessel vasculitis
Autor: T. V. Beketova, a další
Vydáno: (2022-03-01)

Large vessel vasculitis: which imaging method?
Autor: Marco A Cimmino, a další
Vydáno: (2017-03-01)

Large-vessel vasculitis and Q fever correlation
Autor: Joana C. Ramos, a další
Vydáno: (2023-12-01)

Perspectives of JAK Inhibitors for Large Vessel Vasculitis
Autor: Ryu Watanabe, a další
Vydáno: (2022-03-01)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
Autor: Suppiah, R, a další
Vydáno: (2011)

Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS)
Autor: Nakagomi, D, a další
Vydáno: (2017)

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis.
Autor: Fuchs, M, a další
Vydáno: (2012)

Comparison of disease activity measures for ANCA-associated vasculitis.
Autor: Merkel, P, a další
Vydáno: (2004)

Vasculitis: an update.
Autor: Luqmani, R
Vydáno: (2014)

Vasculitis: an update.
Autor: Luqmani, R
Vydáno: (2014)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
Autor: Suppiah, R, a další
Vydáno: (2011)